SEC Comment Letter 0000000000-24-000644 to PRF Technologies Ltd. (PRFX)
PRF Technologies Ltd.
Date: Jan. 18, 2024 · CIK: 0001801834 · Accession: 0000000000-24-000644
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276485
Letter
United States securities and exchange commission logo January 18, 2024 Ilan Hadar Chief Executive Officer PainReform Ltd. 65 Yigal Alon St. Tel Aviv, Israel 6744316 Re:PainReform Ltd. Registration Statement on Form F-3 Filed January 12, 2024 File No. 333-276485 Dear Ilan Hadar: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Cindy Polynice at 202-551-8707 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Gary Emmanuel, Esq.
Show Raw Text
United States securities and exchange commission logo
January 18, 2024
Ilan Hadar
Chief Executive Officer
PainReform Ltd.
65 Yigal Alon St.
Tel Aviv, Israel 6744316
Re:PainReform Ltd.
Registration Statement on Form F-3
Filed January 12, 2024
File No. 333-276485
Dear Ilan Hadar:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Cindy Polynice at 202-551-8707 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Gary Emmanuel, Esq.